Literature DB >> 21625076

Gynecomastia as a first clinical sign of nonseminomatous germ cell tumor.

N Kolitsas1, S Tsambalas, F Dimitriadis, D Baltogiannis, E Vlachopoulou, S Vappa, D Giannakis, P Tsounapi, A Takenaka, N Sofikitis.   

Abstract

INTRODUCTION: Gynecomastia is a common clinical sign in several diseases. In this report we present a case of gynecomastia with underlying testicular tumor which remained misdiagnosed for a prolonged period of time. CASE REPORT: A 16-year-old adolescent noticed unilateral painless swelling of the left breast. He was referred to the Department of General Surgery and examined by a breast surgeon. A diagnosis of mastitis was made and a treatment with an oral antibiotic drug began. After failure of the initial antibiotic treatment, the patient was referred to the Department of Endocrinology and left testicular cancer was diagnosed. Unilateral high inguinal orchidectomy and subsequent chemotherapeutic treatment were performed.
CONCLUSION: Primary care physicians should be aware of the possibility of a concomitant presence of gynecomastia and testicular cancer. We suggest a physical examination as well as a laboratory investigation, and testicular ultrasonography of the testes in all patients with gynecomastia.
Copyright © 2011 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2011        PMID: 21625076     DOI: 10.1159/000328387

Source DB:  PubMed          Journal:  Urol Int        ISSN: 0042-1138            Impact factor:   2.089


  3 in total

1.  Is gynecomastia related to the disease characteristics and prognosis in testicular germ cell tumor patients?

Authors:  Ahmet Veysel Polat; Mesut Öztürk; İlkay Çamlıdağ; Behiç Akyüz
Journal:  Diagn Interv Radiol       Date:  2019-05       Impact factor: 2.630

Review 2.  Gynecomastia and hormones.

Authors:  Andrea Sansone; Francesco Romanelli; Massimiliano Sansone; Andrea Lenzi; Luigi Di Luigi
Journal:  Endocrine       Date:  2016-05-04       Impact factor: 3.633

3.  CT measurement of breast glandular tissue and its association with testicular cancer.

Authors:  Eyal Klang; Noa Rozendorn; Steve Raskin; Orith Portnoy; Miri Sklair; Edith M Marom; Eli Konen; Michal M Amitai
Journal:  Eur Radiol       Date:  2016-05-26       Impact factor: 5.315

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.